A Process For The Preparation Of Form Iii Of Cortexolone 17 A Propionate

Pulse Pharmaceuticals Pvt Ltd
Reply Not Filed App No 202341061335 Chemical

Patent information

IP India · live record
Application number
202341061335
Filing date
12 September 2023
Status
Reply Not Filed
Publication number
11/2025
Publication type
INA
Invention field
Chemical

Abstract

ABSTRACT A PROCESS FOR THE PREPARATION OF FORM III OF CORTEXOLONE 17a-PROPIONATE Disclosed herein is a process for the preparation of crystalline form III of cortexolone 17a-propionate of formula (I) Formula (I) which comprises providing a solution of cortexolone 17a-propionate in ethanol; combining the solution of cortexolone 17a-propionate with n-hexane to obtain a mixture; maintaining the mixture at a temperature between 0 oC and 5 oC and stirring the mixture for a time between 25 and 35 minutes; and isolating crystalline Form III of cortexolone 17a-propionate.

Applicants

1
India
PULSE PHARMACEUTICALS PVT LTD #18/1, Sector-III, Hitech City, Hyderabad, TS, India 500081

Inventors

4
India
RAGHUBABU KOLLAMig-220, Balaji Nagar, kukatpally, Hyderabad, TS 500072
India
SREENIVASARAO RAVURISaikrishna towers, Flat no:502, Balkampet, SR Nagar, Hyderabad, TS 500038
India
PURNACHANDRARAO KUNDETIBalakrishna convention, Flat no-502, Mallikarjunapuram colony, Guntur, AP
India
KATRAGADDA VENKATA RAMBABUVilla no:17, Ektha prime highland park, Financial Dt, Near continental Hospital, Gachibowli, Serilingampally, KvRangareddy, TS -500032

Specification

Show full textCollapse

1. A process for the preparation of crystalline Form III of Cortexolone 17α-propionate of formula (I) 2. The process as claimed in Claim 1, wherein the amount of ethanol used for providing a solution of cortexolone 17α-propionate in ethanol in step a) is about 3 ml per gram of cortexolone 17α-propionate. 3. The process as claimed in Claim 1, wherein ethanol and n-hexane are used in the 25 ratio of about 1:2. 4. The process as claimed in Claim 1, wherein the water content of the mixture is less than about 10%. 5. The process as claimed in Claim 1, wherein the mixture obtained in step b) is cooled to a temperature of about 0 oC (± 2 oC), maintained at a temperature of 0 oC (± 2 oC) and stirred for 30 minutes at 0 oC (± 2 o 10 C). 6. The process as claimed in Claim 1, wherein the crystalline Form III of cortexolone 17α-propionate is isolated by filtration and is further washed with n-hexane. 15 7. The process as claimed in Claim 6, wherein the isolated crystalline Form III of cortexolone 17α-propionate is dried at temperatures from about 40°C to about 50°C, under a vacuum for a time between about 7 hours and about 9 hours. 8. The process as claimed in Claim 1, wherein the crystalline Form III of Cortexolone 20 17α-propionate is stable and has a purity of greater than 99.0%, wherein stable means that after 2 months at 25±2°C and 60±5% relative humidity or at 2-8°C all impurities are below 1.0%. 9. The process as claimed in Claim 1, wherein the crystalline Form III of cortexolone 25 17α-propionate is characterized by a powder x-ray diffraction pattern as substantially depicted in FIG. 1. 10. The process as claimed in Claim 1, wherein the crystalline Form III of cortexolone 17α-propionate is characterized by a powder x-ray diffraction pattern having peaks 30 at about 6.35, 12.71, 14.18, 14.4, 16.1, 22.5, and 23.8 degrees 2 theta (±0.2°).

Documents

Sign in to open
Application documents
1 202341061335-STATEMENT OF UNDERTAKING (FORM 3) [12-09-2023(online)].pdf 12 Sep 2023
2 202341061335-POWER OF AUTHORITY [12-09-2023(online)].pdf 12 Sep 2023
3 202341061335-FORM 1 [12-09-2023(online)].pdf 12 Sep 2023
4 202341061335-FIGURE OF ABSTRACT [12-09-2023(online)].pdf 12 Sep 2023
5 202341061335-DRAWINGS [12-09-2023(online)].pdf 12 Sep 2023
6 202341061335-DECLARATION OF INVENTORSHIP (FORM 5) [12-09-2023(online)].pdf 12 Sep 2023
7 202341061335-COMPLETE SPECIFICATION [12-09-2023(online)].pdf 12 Sep 2023
8 202341061335-OTHERS [16-07-2025(online)].pdf 16 Jul 2025
9 202341061335-MSME CERTIFICATE [16-07-2025(online)].pdf 16 Jul 2025
10 202341061335-FORM28 [16-07-2025(online)].pdf 16 Jul 2025
11 202341061335-FORM FOR SMALL ENTITY [16-07-2025(online)].pdf 16 Jul 2025
12 202341061335-FORM 18A [16-07-2025(online)].pdf 16 Jul 2025
13 202341061335-EVIDENCE FOR REGISTRATION UNDER SSI [16-07-2025(online)].pdf 16 Jul 2025
14 202341061335-FER.pdf 18 Jul 2025
Search strategy
1202341061335_SearchStrategyNew_E_202341061335E_17-07-2025.pdf